Can “hybrid stent implantation” improve the long-term safety without affecting efficacy adversely wh

来源 :第11届中国介入心脏病学大会 | 被引量 : 0次 | 上传用户:xulingxuan
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Though DES almost solved problem ofrestenosis, safety issue caused by stent thrombsis is still the major concern of DES.We hypothesized that hybrid stem implantation (BMS for lesions located at vessles with lumen size≥3.5 mm, DES for other lesions) may decrease the use of DES which probably improving the long-term safety but not affecting efficacy adversely when treating mutilesion coronary artery disease in DES era.
其他文献
Background Cigarette smoking is independent risk factor of cardiovscular disease.Numerous studies have shown that smoking cause significant endothelial dysfunction, inflammatory state, triggering of c
会议
Background Coronary artery chronic occlusion (CTO) lesions are usually the coronary occlusion pathological changes beyond 3 months; incidence of coronary heart disease is about 20%-40%.CTO lesions suc
会议
Background Long-term outcomes of percutaneous coronary intervention (PCI) with sirolimus-eluting stents (SES)compared to paclitaxel-eluting-stents (PES) in unselected diabetics in routine practice is
会议
Background A series of clinical studies had revealed that delayed neointimal coverage and uncovered struts remained visible after long-time follow-up, mostly at 6 to 12 months after drug-eluting stent
会议
Background Patients with acute ST-segment elevation myocardial infarction (STEMI), primary angioplasty is often accompanied with myocardial perfusion bad, no-reflow reperfusion that influences both mo
会议
Background To compare the safety and efficacy at 24 months after successful implantation of FIREBIRDsirolimus-eluting stents and TAXUS paclitaxel-eluting stents in Chinese population Methods From Apri
会议
Background Recent data has shown that sirolimus-eluting stents (SES) reduced not only the incidences of restenosis but also of target vessel revascularization (TVR).CYPHER and FIREBIRD stents are both
会议
Background TIMI Myocardial Perfusion Frame Count (TMPFC) developed by our medical center is a novel technique using coronary cine-angiography for quantifying the filling and clearance of contrast agen
会议
Background To study the effects and mechanism of high dose atorvastatin on prevention of contrast-induced nephropathy.Methods All 180 patients undergoing CAG and/or PCI were randomly divided into 20 m
会议
Background This study sought to evaluate the safety and efficacy of the NOYA stent which is a Cobalt Chromium-based sirolimus-eluting stent (SES) with DL-Polylactide biodegradable polymer (Medfavour M
会议